Best Alzheimer's and Dementia Research Grants in Vermont

The McKnight Brain Research Foundation Innovator Awards aim to support innovative research in cognitive aging and memory loss, offering two 3-year grants of $750,000 each. Targeted at early-career investigators, the program encourages high-risk, high-gain proposals that explore clinical translational research and the biological mechanisms of cognitive aging. By fostering emerging scientific leaders, the initiative seeks to advance transformative discoveries in this critical area of aging research, enhancing understanding and treatment of age-related cognitive decline.

The JTMF Foundation Grant focuses on improving the lives of individuals in need, particularly in the Pacific Northwest. By partnering with organizations addressing immediate needs and long-term challenges, the foundation supports children, older adults, veterans, and individuals with intellectual and developmental disabilities. Guided by Catholic values, JTMF aims to empower communities while seeking innovative solutions to societal issues. Organizations that align with these focus areas are encouraged to connect, fostering a collaborative effort towards meaningful impact.

Nonprofit AFA member organizations in Vermont and nationwide can apply for the Alzheimer’s Foundation of America’s bi-annual grants, awarding US $6,000 for dementia-related programs and services. Funding can support administrative costs, staff salaries and training, occupancy, and supplies or equipment for new or existing Alzheimer’s and dementia initiatives.

Academic and research institutions conducting Alzheimer’s and dementia-related research in Vermont and other U.S. locations can seek funding to run intensive postbaccalaureate research education programs. Grants from US Dept. of Health & Human Services: National Institutes of Health support one-to-two-year mentored AD/ADRD research experiences, combining independent projects with structured academic and professional development, with awards up to US $400,000.

Vermont research institutions and education-focused organizations can seek funding to run summer Alzheimer’s and dementia research education programs for high school students, undergraduates, or science teachers. Vermont dementia and Alzheimer’s groups can access funding through National Institutes of Health for hands-on AD/ADRD research experiences and complementary STEM enrichment, with awards up to US $200,000.

Early-career dementia and Alzheimer’s disease researchers worldwide, including those based in Vermont, can apply for the Alzheimer’s Association Research Grant For All program, which awards US $70,000 - US $200,000 for pilot and preliminary studies. Funding supports newly independent investigators developing data and hypotheses across basic, translational, clinical, psychosocial, and care-focused research.

Nonprofit 501(c)(3) organizations with at least two years of operation working on dementia care and brain degenerative disease support in Vermont can seek project funding to improve care, support, and quality of life for older adults. The Sephardic Home for the Aged Foundation encourages innovative aging-related programs within its broader U.S. grantmaking.

Postdoctoral researchers working on Alzheimer’s or dementia-related research, including those based in Vermont, can apply for up to US $200,000 from the Alzheimer’s Association to advance their early careers. Funding supports mentored projects that build toward independent research in understanding, diagnosing, or treating Alzheimer’s and other dementias, with encouragement for underrepresented investigators.

Licensed clinician scientists working on dementia and Alzheimer’s research, including those in Vermont, can apply for Alzheimer’s Association fellowships awarding up to US $250,000 to support their training and research. This program encourages applicants from underrepresented groups and supports clinical and patient-related diagnostic research careers in Alzheimer’s and other dementias.

Alzheimer’s-focused nonprofit member organizations of the Alzheimer’s Foundation of America in Vermont can apply for the Anne & Irving Brodsky Innovation Grant, awarding US $25,000 for innovative programs improving life for individuals with Alzheimer’s or related dementias and their families. Funding can cover staff, training, occupancy, supplies, equipment, and related administrative or travel costs.

Public safety agencies in Vermont working on dementia and Alzheimer’s wandering prevention and related public safety initiatives can receive support for administrative costs, staff training, supplies, equipment, and community education. Alzheimer’s Foundation of America provides these U.S. grants, awarding up to US $6,000 twice a year to eligible Project Lifesaver International member agencies.

Focused on dementia and Alzheimer’s care, Alzheimer’s Foundation of America invites Vermont organizations serving individuals with Alzheimer’s and related dementias to apply for Milton & Phyllis Berg Family Respite Care Grants. AFA member organizations can receive US $6,000 to provide respite care scholarships and cover supplies, equipment, capacity building, administrative expenses, and staff training.

Research institutions and medical centers in Vermont studying Alzheimer’s and other dementias can apply for the Alzheimer’s Association and ASNR Imaging Research Grant; awards US $200,000 for early-stage pilot projects. Funding supports development of novel imaging tools and innovative imaging data analysis for neurodegenerative disease research over one year.

Research institutions studying aging, Alzheimer’s disease, or related dementias in Vermont and nationwide can apply for upcoming NIH R01 funding to investigate mechanisms linking olfactory decline with AD/ADRD. This National Institute on Aging and NIDCD opportunity supports cellular, molecular, imaging, physiological, omics, and other approaches in human or animal studies of smell and neurodegeneration.

Research institutions and investigators studying cerebellar roles in cognition and emotion in aging and Alzheimer’s disease can apply for R01 research funding from the National Institutes of Health. This opportunity supports basic, animal, human, and secondary data studies, including potential intervention targets, and may benefit Vermont-based Alzheimer’s and dementia research programs.

Families needing in-home care companions or respite aides for loved ones with Alzheimer’s or other dementias in the Boyertown Area School District can receive support for several days of care. Berks County Community Foundation’s Margaret B. Moeller Fund offers US $200 - US $3,000 for those not eligible for other reimbursement sources and may benefit Vermont-focused dementia caregivers researching support models.

Research institutions and teams conducting preclinical Alzheimer’s and dementia drug discovery can apply for National Institutes of Health support, including Vermont-based investigators. This upcoming U01 opportunity will fund rigorous target validation and early-stage development of small molecules, biologics, and other therapeutic modalities, and may benefit Vermont organizations focused on Alzheimer’s and dementia research.

Research institutions and collaborative teams studying mechanisms of neurodegeneration in Alzheimer’s disease-related dementias in Vermont and other U.S. locations can apply for National Institutes of Health “Center without Walls” support. Funding backs interdisciplinary consortia using advanced technologies, disease-relevant models, clinical science, and human specimens to uncover novel ADRD mechanisms, biomarkers, and therapeutic targets.

Research institutions studying how environmental and neural exposome factors affect Alzheimer’s disease-related dementias can apply for National Institutes of Health funding, including work in Vermont and other U.S. locations. Projects should examine synergistic effects of exposures and mechanistic pathways underlying ADRD pathology, progression, resilience, and potential neurological health disparities across the lifespan.

Research institutions and teams conducting dementia and Alzheimer’s disease studies in Vermont and other eligible U.S. locations can apply for National Institutes of Health funding to functionally validate new therapeutic targets. This phased support backs technology and model development, then rigorous cross-validation of target modulation to accelerate future translational research on Alzheimer’s disease-related dementias.

Vermont research institutions and affiliated organizations studying dementia and Alzheimer’s disease care can access funding through the Alzheimer’s Association to investigate detection, diagnosis, and post-diagnostic care pathways. Awards up to US $250,000 support rigorous health services research on early detection value and care pathways for individuals with MCI or dementia.

The NIH Blueprint for Neuroscience Research Network aims to enhance foundational research on human consciousness, addressing critical biomedical issues such as coma and dementia. By fostering a collaborative framework among 14 NIH institutes, the initiative seeks to improve diagnosis and treatment of neurological disorders through interdisciplinary approaches. Key objectives include detecting consciousness in minimally responsive patients, enhancing understanding of sleep disorders, and exploring new methodologies. This effort will ultimately strengthen U.S. leadership in neuroscience and improve patient outcomes.

The DoW Alzheimer’s Transforming Research Award supports innovative research aimed at reducing the risk and preventing Alzheimer’s disease and related dementias. It emphasizes projects that enhance understanding of risk factors and develop effective risk reduction strategies. Clinical research is permitted, but trials and animal studies are not. Collaboration and preliminary data are essential for proposal consideration, and an option for multiple principal investigators is available to foster partnerships.

The FY26 Alzheimer’s Research Program's Transforming Diagnosis Award (TrDA) promotes innovative research aimed at overcoming significant barriers to accurate diagnosis and monitoring of Alzheimer's disease. This award encourages community collaboration and requires preliminary data. It supports studies leveraging existing cohorts, especially those including individuals aged 65 and younger. The TrDA also offers a partnership option for multiple principal investigators, fostering collaborative research efforts while ensuring at least one independent investigator meets eligibility criteria.

The DoW Alzheimer’s Transforming Care Award aims to support innovative clinical research and trials enhancing dementia care for individuals with Alzheimer’s disease. This funding opportunity encourages collaborative partnerships and requires preliminary data, focusing on interventions that do not solely test pharmacological solutions. Community collaboration is essential, and studies leveraging existing cohorts, including those with younger participants, are encouraged. The award supports both new and existing partnerships among principal investigators.

The NIA Genetics of Alzheimer’s Disease Data Storage Site (NIAGADS) aims to create a secure, scalable cloud platform for genetic data related to Alzheimer’s disease. This initiative will enhance data accessibility, promote interoperability, and support rigorous research practices. By facilitating collaboration and providing robust analytical tools, the platform will maximize the scientific impact of AD/ADRD research, aligning with NIH goals for transparent and reproducible science, while addressing recommendations for broad access to high-value datasets.

Researchers and early-career investigators working on dementia and Alzheimer’s disease in Vermont can access funding to advance understanding, prevention, and treatment through BrightFocus Foundation, with awards ranging from US $200,000 - US $300,000. Grants support both standard projects led by new investigators and postdoctoral fellowships for scientists in mentored training.